Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012;7(12):e52291.
doi: 10.1371/journal.pone.0052291. Epub 2012 Dec 18.

Optic nerve magnetisation transfer ratio after acute optic neuritis predicts axonal and visual outcomes

Affiliations

Optic nerve magnetisation transfer ratio after acute optic neuritis predicts axonal and visual outcomes

Yejun Wang et al. PLoS One. 2012.

Erratum in

  • PLoS One. 2012;7(12). doi: 10.1371/annotation/1c474016-06ef-4827-8fe8-82c158d7616b

Abstract

Magnetisation transfer ratio (MTR) can reveal the degree of proton exchange between free water and macromolecules and was suggested to be pathological informative. We aimed to investigate changes in optic nerve MTR over 12 months following acute optic neuritis (ON) and to determine whether MTR measurements can predict clinical and paraclinical outcomes at 6 and 12 months. Thirty-seven patients with acute ON were studied within 2 weeks of presentation and at 1, 3, 6 and 12 months. Assessments included optic nerve MTR, retinal nerve fibre layer (RNFL) thickness, multifocal visual evoked potential (mfVEP) amplitude and latency and high (100%) and low (2.5%) contrast letter acuity. Eleven healthy controls were scanned twice four weeks apart for comparison with patients. Patient unaffected optic nerve MTR did not significantly differ from controls at any time-point. Compared to the unaffected nerve, affected optic nerve MTR was significantly reduced at 3 months (mean percentage interocular difference = -9.24%, p = 0.01), 6 months (mean = -12.48%, p<0.0001) and 12 months (mean = -7.61%, p = 0.003). Greater reduction in MTR at 3 months in patients was associated with subsequent loss of high contrast letter acuity at 6 (ρ = 0.60, p = 0.0003) and 12 (ρ = 0.44, p = 0.009) months, low contrast letter acuity at 6 (ρ = 0.35, p = 0.047) months, and RNFL thinning at 12 (ρ = 0.35, p = 0.044) months. Stratification of individual patient MTR time courses based on flux over 12 months (stable, putative remyelination and putative degeneration) predicted RNFL thinning at 12 months (F(2,32) = 3.59, p = 0.02). In conclusion, these findings indicate that MTR flux after acute ON is predictive of axonal degeneration and visual disability outcomes.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: Dr. van der Walt has received travel support from Bayer Australia and Sanofi Aventis. She has received unrestricted grants from Bayer Asutralia and Biogen Idec. Dr. Klistorner is supported by an unrestricted grant from Biogen Idec. Dr. Butzkueven has served on scientific advisory boards for Biogen Idec, Novartis and Sanofi-Aventis and has received conference travel support from Novartis, Biogen Idec andSanofi Aventis. He serves on steering committees for trials conducted by Merck Serono, Biogen Idec and Novartis. Dr. Butzkueven has received research support from Merck Serono, Novartis and Biogen Idec in his capacity as honorary chair of the MSBase Foundation. Dr. Kilpatrick has served on scientific advisory boards for GlaxoSmithKline, Neurosciences Victoria and the Victorian Neurotrauma Initiative; has received funding for travel from Bayer Schering pharma, Sanofi Aventis and Merck Serono; served on the editorial board of Therapeutic Advances in Neurological Disorders; is listed as an inventor on patents re: HIV test kit method for detecting anti-HIV-1 antibodies in saliva; A method of modulating cell survival and reagents useful for the same; Methods for the treatment and prophylaxis of demyelinating disease; and Method of treatment in the field of inflammatory neurodegeneration; and receives research support from Bayer Schering Pharma, Biogen IDEC. Dr. Egan serves on an ARC college of experts panel for which he receives personal compensation, he is a member of the Neurosciences Victoria scientific advisory board; he has received travel expenses and/or honoraria for lectures or educational activities not funded by industry; he is an associate editor of Human Brain Mapping, he serves on the editorial boards of Neuroimage and the Journal of Imaging Technology.

Figures

Figure 1
Figure 1. Serial measurements of MTR in patient affected and unaffected optic nerves during the 12 months following acute optic neuritis.
Significant differences were observed at three, six and 12 months (** indicates p<0.01 for paired t-test). The control distribution is indicated on the left for comparison. Errorbars indicate one standard error of the mean (SEM).
Figure 2
Figure 2. Individual patient MTR asymmetry time courses (grey lines) and mean fitted time courses (black lines) for three subgroups defined based on the pattern of MTR flux.
*p<0.05.
Figure 3
Figure 3. Scatterplots showing distributions for RNFL thinning (upper) and mfVEP amplitude loss (lower) based on subgroups.
*p<0.05.

Similar articles

Cited by

References

    1. Group ONS (1991) The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol 109: 1673–1678. - PubMed
    1. Regan D, Silver R, Murray T (1977) Visual acuity and contrast sensitivity in multiple sclerosis–hidden visual loss: an auxiliary diagnostic test. Brain: a journal of neurology 100: 563. - PubMed
    1. Halliday A, McDonald W, Mushin J (1972) Delayed visual evoked response in optic neuritis. The Lancet 299: 982–985. - PubMed
    1. Costello F, Coupland S, Hodge W, Lorello GR, Koroluk J, et al. (2006) Quantifying axonal loss after optic neuritis with optical coherence tomography. Annals of neurology 59: 963–969. - PubMed
    1. Costello F, Hodge W, Pan Y, Eggenberger E, Coupland S, et al. (2008) Tracking retinal nerve fiber layer loss after optic neuritis: a prospective study using optical coherence tomography. Multiple Sclerosis 14: 893–905. - PubMed

Publication types